Dementia: A cross-cultural perspective on risk factors

From: Generations | Date: April 1, 2002| Author: Gatz, Margaret; Watari, Kecia | Copyright information

Dementia is one of the most devastating mental illnesses that affect older adults, accounting for a large proportion of new cases of mental illness in old age and causing significant distress to individuals and their families. This paper provides a review of research on the frequency of dementia and the factors that put people at risk, with implications for prevention and intervention. Where possible, we address ethnic or cultural differences. However, while ethnic minority elders are a rapid...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

Dementia: A cross-cultural perspective on risk factors
Generations ; Dementia is one of the most devastating mental illnesses that affect older adults, accounting for a large proportion of new cases of mental illness in old age and causing significant distress to individuals and their families. This paper provides a review of research on the frequency of dementia
Stroke history raises risk of vascular dementia.(care and treatment)
Clinical Psychiatry News ; PORTO, PORTUGAL -- Stroke was associated with a nearly 20-fold increase in risk for vascular dementia in a univariate, retrospective, case-control analysis presented at the Fourth International Congress on Vascular Dementia. Among 205 people with vascular dementia and their control cases, those
Use of Antidementia Agents in Vascular Dementia: Beyond Alzheimer Disease
Mayo Clinic Proceedings ; Vascular dementia (VaD) is the second leading cause of dementia and is often underdiagnosed. Stroke is the leading cause of VaD, although it may also develop secondary to a variety of other cerebrovascular or cardiovascular conditions. Currently, no drugs are approved for the treatment of VaD.
Vascular dementia. (Featured CME Topic: Stroke).(medical research)
Southern Medical Journal ; The relationship between vascular disease of the brain and cognitive impairment is unclear. It is known that extensive vascular lesions in the brain, large or small, can cause dementia. What is not known is how often this occurs and by what mechanism. Also unclear is the extent of overlap between
SPECT and vascular dementia
The Journal of Nuclear Medicine ; SPECT is a proven method for assessing cerebral blood flow (CBF) in patients with vascular dementia. In a study published in the February issue of the Journal of Neurology (2003;250:194-200), Yoshikawa et al., from Osaka University Graduate School of Medicine (Osaka, Japan), reported on the use of
Aricept setback in vascular dementia trials.(Disease/Disorder overview)(Brief article)
Healthy Years ; Eleven of 648 patients died recently while taking Aricept in a phase-three trial of the drug to investigate its use to treat vascular dementia. Aricept has been used for about a decade to counteract mild to moderate Alzheimer's disease; this trial by the Eisai company, makers of the drug, was part
Donepezil in the treatment of vascular dementia.(Cochrane Briefs)
American Family Physician ; Clinical Question Is donepezil effective in the treatment of vascular dementia? Evidence-Based Answer Donepezil in a dosage of 10 mg daily provides a small benefit in patients with mild to moderate vascular dementia and generally is well tolerated. Practice Pointers Donepezil, a cholinesterase
Eleven deaths reported in donepezil vascular dementia trial.(Neuropsychiatric Medicine)
Clinical Psychiatry News ; Eleven of 648 patients died while taking donepezil (Aricept) in a trial of the drug for the treatment of vascular dementia, according to preliminary study results announced by Eisai Co. Ltd., the drug's maker. None of the 326 patients taking placebo during the 24-week trial died. The multicenter,
New Alzheimer's drug is first therapy to show efficacy in vascular dementia
Formulary ; A new 12-month study offers the first evidence suggesting that drug therapy may improve cognition and functioning in patients with dementia related to cerebrovascular disease. The drug is galantamine hydrobromide (Reminyl), which was approved earlier this year for treatment of mild to moderate
Quantitative EEG diagnostic of vascular dementia severity.
Clinical Psychiatry News ; PORTO, PORTUGAL -- Quantitative EEG shows promise as a clinical diagnostic tool that is sensitive enough to distinguish mild from moderate subcortical dementia, according to one study presented at the Fourth International Congress on Vascular Dementia. Quantitative EEG results correlated strongly